IndraLab

Statements


USP49 activates PI3K. 1 / 1
| 1

reach
"In conclusion, we demonstrated that USP49 was functional in NSCLC cells, and inhibited NSCLC cell growth by suppressing PI3K and AKT signaling, suggesting that USP49 could be as a novel target for NSCLC therapy."